That is true. The Europeans were pushing for a five-year extension, which would have been a 25-year patent. The CETA negotiators managed to mitigate that, to reduce it to a two-year extension. That's what the bill says, and we believe it should be no longer than that.
As for the Ontario government, our sector has many of its jobs in Ontario. I think, from the Ontario perspective, it wants access to low-cost generics on a timely basis. It is also supportive of our sector and the high-tech jobs we have. We have enjoyed support from the Ontario government in ensuring that the excessive demands from Europe were not always accepted during the negotiations.